Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults
2022 · Nature Microbiology · 135 citations
https://doi.org/10.1038/s41564-022-01237-2
M
Mazin Abdelghany
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
1.7K
Citations
9
h-index
8
i10-index
Mazin Abdelghany is an academic researcher from Gilead Sciences (United States). The author has contributed to research in topics: COVID-19 Clinical Research Studies & Gut microbiota and health & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 9, co-authored 32 publications.
ORCID: 0000-0001-5192-8659Papers by this author
worksMetagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections
2022 · Genome Medicine · 105 citations
https://doi.org/10.1186/s13073-022-01072-4
SARS-CoV-2 resistance analyses from the Phase 3 PINETREE study of remdesivir treatment in nonhospitalized participants
2024 · Antimicrobial Agents and Chemotherapy · 3 citations
https://doi.org/10.1128/aac.01238-24
Risk of Long COVID in hospitalized individuals treated with remdesivir for acute COVID-19
2025 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-025-06052-3
Additional file 9 of Metagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.20289177
Additional file 7 of Metagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.20289171
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat